Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rivus Pharmaceuticals
Biotech
Sarepta CEO to step down as DM1 hits home—Chutes & Ladders
Sarepta CEO to step down as DM1 hits close to home. Pops descends from Alkermes CEO seat. Former Novartis CMO Tsai saunters to Daiichi.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Feb 27, 2026 8:30am
Moderna CMO steps down in leadership mix-up—Chutes & Ladders
Feb 6, 2026 8:30am
Rivus weight loss drug shows MASH win, muscle-sparing potential
Jun 24, 2025 10:07am
J&J innovator vaults to Valo—Chutes & Ladders
Apr 11, 2025 8:30am
Rivus posts data to back up muscle-sparing obesity drug claims
Sep 30, 2024 11:09am
Rivus’ phase 2 obesity-related heart failure trial hits endpoint
Aug 13, 2024 8:57am